Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock closed at 4.29 per share at the end of the most recent trading day (a -0.69% change compared to the prior day closing price) with a volume of 76.60K shares and market capitalization of 62.42M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 275 people. Accelerate Diagnostics Inc. CEO is John Phillips.

The one-year performance of Accelerate Diagnostics Inc. stock is 423.13%, while year-to-date (YTD) performance is 507.65%. AXDX stock has a five-year performance of -70.95%. Its 52-week range is between 3.81 and 11.9, which gives AXDX stock a 52-week price range ratio of 5.93%

Accelerate Diagnostics Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 89.93, a price-to-sale (PS) ratio of 6.45, a price to cashflow ratio of 213.80, a PEG ratio of -, a ROA of -97.50%, a ROC of -51.28% and a ROE of 324.31%. The company’s profit margin is -%, its EBITDA margin is -474.00%, and its revenue ttm is $9.78 Million , which makes it $0.10 revenue per share.

Of the last four earnings reports from Accelerate Diagnostics Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.94 for the next earnings report. Accelerate Diagnostics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Accelerate Diagnostics Inc. is Strong Buy (1), with a target price of $5, which is +16.55% compared to the current price. The earnings rating for Accelerate Diagnostics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accelerate Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accelerate Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.43, ATR14 : 0.42, CCI20 : -107.21, Chaikin Money Flow : -0.48, MACD : -0.44, Money Flow Index : 9.71, ROC : -18.13, RSI : 28.57, STOCH (14,3) : 20.08, STOCH RSI : 0.51, UO : 35.77, Williams %R : -79.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accelerate Diagnostics Inc. in the last 12-months were: Brink Frank Jm Ten (Option Excercise at a value of $0), Brown Thomas (Option Excercise at a value of $0), Burris Wayne (Sold 0 shares of value $0 ), David Patience (Sold 0 shares of value $0 ), David Patience (Sold 4 040 shares of value $5 120 ), Francesconi Louise (Option Excercise at a value of $0), Frank J.M. Ten Brink (Option Excercise at a value of $0), Jack Phillips (Option Excercise at a value of $0), Jack Phillips (Sold 367 634 shares of value $180 362 ), Larry Michael Mertz (Option Excercise at a value of $0), Larry Michael Mertz (Sold 33 401 shares of value $16 366 ), Mark C. Miller (Option Excercise at a value of $0), Massarany Hany (Option Excercise at a value of $0), Miller Mark (Option Excercise at a value of $0), Patience David (Option Exercise at a value of $0), Patience David (Sold 92 shares of value $635 ), Phillips Jack (Option Excercise at a value of $0), Phillips Jack (Option Exercise at a value of $0), Phillips Jack (Sold 234 823 shares of value $148 345 ), Schuler Jack (Option Excercise at a value of $0), Steve Reichling (Option Excercise at a value of $0), Steve Reichling (Sold 77 039 shares of value $37 970 ), Steven Reichling (Option Excercise at a value of $0), Steven Reichling (Sold 77 039 shares of value $37 970 ), Watts Charles (Option Excercise at a value of $0)